Priyam Shah | Head of IR |
Brian McKelligon | CEO |
Joseph Driscoll | CFO |
Neil Vibhakar | Morgan Stanley |
Kyle Mikson | Canaccord Genuity |
Mark Massaro | BTIG |
David Westenberg | Piper Sandler |
Thank you for standing by, and welcome to the Akoya Biosciences Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. And now I'd like to introduce your host for today's program, Priyam Shah, Head of Investor Relations.